Cost-effectiveness of detemir based basal-bolus therapy versus NPH for type 1 diabetes in a Spanish setting

被引：0

作者：

Ray, J. A.

Valentine, W. J.

Goodall, G.

Aagren, M.

Kotchie, R. W.

机构：

[1] IMS Hlth, Hlth Econ Dept, Basel, Switzerland

[2] Novo Nordisk AS, DK-2880 Bagsvaerd, Denmark

[3] IMS Hlth, Hlth Econ Dept, London, England

来源：

DIABETOLOGIA | 2007年 / 50卷

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1033

引用

页码：S428 / S428

页数：1

共 50 条

[41] Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin
De Leeuw, I
Vague, P
Selam, JL
Skeie, S
Lang, H
Draeger, E
Elte, JWF
DIABETES OBESITY & METABOLISM, 2005, 7 (01): : 73 - 82
[42] Visceral fat mass in patients with type 2 diabetes is reduced during insulin detemir-based basal bolus therapy, whereas it is increased during NPH-insulin-based basal bolus therapy
Tinahones, Francisco J.
Martin, Miguel
Macias-Gonzalez, Manuel
DIABETES, 2008, 57 : A167 - A167
[43] Compared to NPH insulin, insulin detemir is associated with a superior efficacy: tolerability profile and reduced excess weight gain when used in basal-bolus therapy for children and adolescents with type 1 diabetes
Robertson, Kenneth
Gall, Mari Anne
HORMONE RESEARCH, 2006, 65 : 57 - 57
[44] Efficacy of Insulin Degludec as Basal-Bolus Therapy After Switching from Insulin Glargine or Insulin Detemir in Young Persons with Type 1 Diabetes
Urakami, Tatsuhiko
Habu, Masako
Okuno, Misako
Suzuki, Junichi
Takahashi, Shori
DIABETES, 2014, 63 : A323 - A323
[45] Evaluation of the cost-effectiveness of insulin glargine versus NPH insulin for the treatment of type 1 diabetes in the UK
McEwan, Phil
Poole, Chris D.
Tetlow, Tony
Holmes, Paul
Currie, Craig J.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 : S7 - S19
[46] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
Cardoso, Cristina
Ramirez de Arellano, Antonio
Prades, Miriam
Lizan, Luis
JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
[47] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
Morales, Cristobal
de Luis, Daniel
Ramirez de Arellano, Antonio
Giovanna Ferrario, Maria
Lizan, Luis
DIABETES THERAPY, 2015, 6 (04) : 593 - 610
[48] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
Cristóbal Morales
Daniel de Luis
Antonio Ramírez de Arellano
Maria Giovanna Ferrario
Luis Lizán
Diabetes Therapy, 2015, 6 : 593 - 610
[49] SHORT-TERM COST-EFFECTIVENESS OF INSULIN DETEMIR VERSUS NPH INSULIN IN INSULIN-NAIVE SUBJECTS WITH TYPE 2 DIABETES IN SWEDEN
Ridderstrale, M.
Ericsson, A.
Jensen, M. M.
VALUE IN HEALTH, 2011, 14 (07) : A480 - A480
[50] Cost-effectiveness analysis of insulin detemir compared to NPH insulin in patients with type-2 diabetes in the United Kingdom
Smith, I
Palmer, AJ
Roze, S
Kennedy-Martin, T
VALUE IN HEALTH, 2004, 7 (06) : 735 - 736

← 1 2 3 4 5 →